The mere presence of oestrogen receptors (ER) is not a reliable criterion for the response of mammary tumours to endocrine therapy. While patients with undetectable levels of tumour ER rarely respond to endocrine therapy, only 50-60% of ER-positive human breast tumours regress following hormone treatment (McGuire et al., 1975) . There is, therefore, a need to identify hormone dependent cancers within the group of ER positive tumours.
In rat mammary tumours, a better assessment of hormone dependency can be achieved by using the ratio of ER to cyclic AMP binding proteins (cAMP BP) compared with either parameter alone (Bodwin et al., 1980) . The aim of this study was to determine whether this ratio would also improve prediction of response to endocrine therapy in patients with advanced breast cancer.
Thirty-one women with ER-positive advanced breast cancer were studied. Premenopausal patients with regular menstrual periods (4 women) were treated by oophorectomy. The Cyclic AMP binding was determined as described previously (Miller et al., 1985) and the activity expressed on the basis of cytosol protein which has been reported to reduce intra-tumoral variation (Senbanjo et al., 1986) . Concentration of oestrogen receptors was determined (in a portion of tumour adjacent to that taken for cAMP BP) by saturation analysis (Hawkins et al., 1981) . Activities in excess of 5 fmol mg-1 cytosol protein were designated receptor positive. Protein content of each cytosol was assayed by the method of Bradford (1976) using bovine albumin as standard.
Of 31 patients, 2 had a complete remission (CR), 12 a partial remission (PR), 2 a static response (NC) and 15 progressive disease (PD) . This represented an overall response rate of 45% (CR +PR) .
The level of ER in tumours, subdivided according to response to endocrine therapy, is shown in Figure 1 . Concentrations of ER were significantly higher in tumours from responding patients as compared with those from the nonresponding group (P< 10-4 These results show, as have others (Edwards et al., 1979; Leclercq & Heuson, 1979) , that patients with tumours having a high concentration of ER are more likely to respond to endocrine therapy than those with ER-poor tumours. However, whilst a statistical difference in ER levels exists between responding and non-responding groups, this does not provide discrimination for individual patients. The presence of progestogen receptors (PgR) in ER positive tumours has been reported to improve the prediction of endocrine responsiveness (Knight et al., 1975) (1987), 56, 141-142 The Macmillan Press Ltd., 1987
Evidence that cAMP BP may represent such a parameter has come from studies in which regression of hormonedependent rat mammary tumours followed administration of dibutyryl cAMP, the effect being apparently mediated by cAMP BP (Cho-Chung & Redler, 1977 ). An inverse relationship has also been described between the binding activities of cAMP and oestrogen during growth and regression of rat mammary tumours (Cho-Chung et al., 1978) . cAMP BPs appear to be a marker of tumour sensitivity to hormonal manipulation, in that by using a ratio of tumour ER to cAMP BP, Bodwin et al. (1980) were able to discriminate by 95% between hormone-dependent and independent rat mammary tumours as compared with a value of 60% using ER alone. A preliminary report from Kvinnsland ct al. (1983) suggests that cAMP binding may also be of value in human breast cancers. Results from our study support this contention. Thus, the ratio of ER to cAMP completely discriminated between responders and non-responders in patients with ER-positive tumours. The cut-off point between the two groups was 45 x 1O-which is different from that used by Kvinnsland et al. (1983) . However, the methodology employed to measure cAMP BP was different in the two studies and is likely to account for the dissimilar ranges of values reported. It is necessary to emphasise that in both studies patient numbers were small and discriminatory levels have been decided retrospectively. These observations require to be extended in a prospective study using a predetermined cut-off point so that the usefulness of the ER to cAMP BP ratio in predicting endocrine responsiveness can be confirmed.
